Onderzoeker
Laura Vangeel
- Disciplines:Microbiologie, Systeembiologie, Laboratoriumgeneeskunde
Affiliaties
- Laboratorium Virologie en Chemotherapie (Rega Instituut) (Afdeling)
Lid
Vanaf1 jul 2020 → 30 jun 2022 - Laboratorium voor Ionenkanaalonderzoek (VIB-KU Leuven) (Afdeling)
Lid
Vanaf3 sep 2013 → 30 jun 2020
Publicaties
1 - 10 van 20
- HIV protease inhibitors Nelfinavir and Lopinavir/Ritonavir markedly improve lung pathology in SARS-CoV-2-infected Syrian hamsters despite lack of an antiviral effect(2022)
Auteurs: Rana Abdelnabi, Suzanne Kaptein, Sebastiaan ter Horst, Leen Delang, Joana Duarte Da Rocha Pereira, Lotte Coelmont, Pieter Leyssen, Kai Dallmeier, Valentijn Vergote, Elisabeth Heylen, et al.
- Discovery of 2-Phenylquinolines with Broad-Spectrum Anti- coronavirus Activity(2022)
Auteurs: Laura Vangeel, Dirk Jochmans, Dominique Schols, Johan Neyts, Steven De Jonghe
Pagina's: 855 - 864 - Ivermectin Does Not Protect against SARS-CoV-2 Infection in the Syrian Hamster Model(2022)
Auteurs: Rana Abdelnabi, Laura Vangeel, Steven De Jonghe, Dirk Jochmans, Birgit Weynand, Johan Neyts
- Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses(2022)
Auteurs: Laura Vangeel, Steven De Jonghe, Dirk Jochmans, Johan Neyts
Pagina's: 2905 - 2920 - The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concern(2022)
Auteurs: Rana Abdelnabi, Dirk Jochmans, Laura Vangeel, Steven De Jonghe, Patrick Augustijns, Birgit Weynand, Johan Neyts
- Synthesis, Structure-Activity Relationships, and Antiviral Profiling of 1-Heteroaryl-2-Alkoxyphenyl Analogs as Inhibitors of SARS-CoV-2 Replication(2022)
Auteurs: Laura Vangeel, Erion Lyoo, Eveline Lescrinier, Pieter Leyssen, Dirk Jochmans, Johan Neyts, Steven De Jonghe
- Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern(2022)
Auteurs: Laura Vangeel, Steven De Jonghe, Piet Maes, Emmanuel Andre, Pieter Leyssen, Johan Neyts, Dirk Jochmans
- A highly potent antibody effective against SARS-CoV-2 variants of concern(2021)
Auteurs: Rana Abdelnabi, Laura Vangeel, Johan Neyts, Pieter Leyssen
- The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model(2021)
Auteurs: Rana Abdelnabi, Suzanne Kaptein, Lana Langendries, Laura Vangeel, Valentijn Vergote, Elisabeth Heylen, Pieter Leyssen, Kai Dallmeier, Lotte Coelmont, Patrick Augustijns, et al.
- A highly potent antibody effective against SARS-CoV-2 variants of concern.(2021)
Auteurs: Rana Abdelnabi, Laura Vangeel, Pieter Leyssen
Pagina's: 109814